ASRT, Dettol hold scientific convention on coronavirus, infection control measures

The president of ASRT Mahmoud Sakr, General Manager of Dettol Egypt Om Prakash, and Head of Dettol R&D Center in the United Kingdom Joseph Rubino have witnessed the joint virtual meeting. A number of Egypt’s leading Pediatrics, Pulmonologists, Dermatologists, Clinical Pathologists, Virologists, and Microbiologists from Cairo and Ain Shams Universities were keen on attending the webinar, together with elite scientific research experts, accompanied by prominent representatives from the ASRT, National Research Center along with Ain Shams University’s Referral Laboratories.

Mahmoud Sakr inaugurated the virtual medical conference praising the sincere endeavors paid by the Egyptian government to boost scientific research activities.

Exhibiting ASRT’s R&D strategies, Sakr noted: “The Academy has integrated with all universities and research centers in Egypt, allocating investments amounting EGP 40 Million to subsidize research, development and innovation projects that alleviate Coronavirus implications. ASRT has partially supported the ongoing research of the National Research Center and set a roadmap to redefine priorities in scientific research based on lessons learned from the Coronavirus pandemic.”

Joseph Rubino showcased the latest findings emerged from Dettol laboratory testing, stating: “Following the release of the novel SARS-CoV-2 strain, Dettol R&D Center commissioned a series of independent laboratory tests with Microbac to assess the effectiveness of Dettol against the virus. To date and post reviewing 70% of our global germ prevention portfolio, Dettol assessed products proved >99.9% efficacy against SARS-CoV-2 known as COVID-19. Such ground-breaking result is to enrich Dettol’s impressive prevention record of its long-proven & tested efficacy against MERS-CoV, H-Cov and Ebola. We are pleased to confirm that the American Journal of Infection Control has recognized the significance of our testing and has published an abstract on its website; emphasizing the competency of Dettol’s high-end products against the novel virus.”

“With 9 key R&D centers and many laboratory testing units across the globe, Dettol leads with science through its 1500 dedicated researchers. Encouraging innovation, science and technology, the company has invested £105 Million (EGP 1,898,820,233) in 2019, establishing a state-of-the-art Science and Innovation Centre in Hull.” Om Prakash, General Manager of Dettol commented.

At press time, the conversion rate is EUR 1 = EGP 18.08